 DURHAM, N.C., March 21, 2022 GLOBE NEWSWIRE -- Chimerix NASDAQ:CMRX, a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that Mike Sherman, Chief Executive Officer, will present a pre-recorded presentation at the Maxim Group 2022 Virtual Growth Conference taking place March 28-30, 2022. 